Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

At similar weight loss, dietary composition determines the degree of glycemic improvement in diet-induced obese C57BL/6 mice.

Vangoitsenhoven R, van der Ende M, Corbeels K, Monteiro Carvalho Mori Cunha JP, Lannoo M, Bedossa P, van der Merwe S, Mertens A, Gesquiere I, Meulemans A, Matthys C, Mathieu C, Overbergh L, Van der Schueren B.

PLoS One. 2018 Jul 23;13(7):e0200779. doi: 10.1371/journal.pone.0200779. eCollection 2018.

2.

Thin bones: Vitamin D and calcium handling after bariatric surgery.

Corbeels K, Verlinden L, Lannoo M, Simoens C, Matthys C, Verstuyf A, Meulemans A, Carmeliet G, Van der Schueren B.

Bone Rep. 2018 Feb 2;8:57-63. doi: 10.1016/j.bonr.2018.02.002. eCollection 2018 Jun.

3.

Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.

Tack J, Rotondo A, Meulemans A, Thielemans L, Cools M.

Neurogastroenterol Motil. 2016 Apr;28(4):487-97. doi: 10.1111/nmo.12736.

PMID:
27010235
4.

A semi-blinded study comparing 2 methods of measuring nasal potential difference: Subcutaneous needle versus dermal abrasion.

De Wachter E, De Schutter I, Meulemans A, Buyl R, Malfroot A.

J Cyst Fibros. 2016 Jan;15(1):60-6. doi: 10.1016/j.jcf.2015.06.007. Epub 2015 Jul 16.

5.

Letter to the editor: Is there a Future for ONS in Acute Geriatric Wards?

Matthys C, Meulemans A, Joosten E.

J Nutr Health Aging. 2015 Jun;19(6):708. doi: 10.1007/s12603-015-0549-1. No abstract available.

PMID:
26054509
6.

Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy.

Shaheen NJ, Adler J, Dedrie S, Johnson D, Malfertheiner P, Miner P, Meulemans A, Poole L, Tack J, Thielemans L, Troy S, Vakil N, Zerbib F, Ruth M.

Aliment Pharmacol Ther. 2015 Apr;41(7):649-61. doi: 10.1111/apt.13115. Epub 2015 Feb 19.

7.

Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment.

Tack J, Zerbib F, Blondeau K, des Varannes SB, Piessevaux H, Borovicka J, Mion F, Fox M, Bredenoord AJ, Louis H, Dedrie S, Hoppenbrouwers M, Meulemans A, Rykx A, Thielemans L, Ruth M.

Neurogastroenterol Motil. 2015 Feb;27(2):258-68. doi: 10.1111/nmo.12484. Epub 2014 Dec 21.

8.

Pregnancy during nitisinone treatment for tyrosinaemia type I: first human experience.

Vanclooster A, Devlieger R, Meersseman W, Spraul A, Kerckhove KV, Vermeersch P, Meulemans A, Allegaert K, Cassiman D.

JIMD Rep. 2012;5:27-33. doi: 10.1007/8904_2011_88. Epub 2011 Dec 16.

9.

Neonatal thyroid-stimulating hormone concentrations in Belgium: a useful indicator for detecting mild iodine deficiency?

Vandevijvere S, Coucke W, Vanderpas J, Trumpff C, Fauvart M, Meulemans A, Marie S, Vincent MF, Schoos R, Boemer F, Vanwynsberghe T, Philips E, Eyskens F, Wuyts B, Selimaj V, Van Overmeire B, Kirkpatrick C, Van Oyen H, Moreno-Reyes R.

PLoS One. 2012;7(10):e47770. doi: 10.1371/journal.pone.0047770. Epub 2012 Oct 24.

10.

Risk factors for elevated levels of 17-hydroxyprogesterone during neonatal intensive care unit admission.

Pauwels G, Allegaert K, Régal L, Meulemans A.

Acta Clin Belg. 2012 Mar-Apr;67(2):88-93.

PMID:
22712163
11.

Radiolabeled fucoidan as a p-selectin targeting agent for in vivo imaging of platelet-rich thrombus and endothelial activation.

Rouzet F, Bachelet-Violette L, Alsac JM, Suzuki M, Meulemans A, Louedec L, Petiet A, Jandrot-Perrus M, Chaubet F, Michel JB, Le Guludec D, Letourneur D.

J Nucl Med. 2011 Sep;52(9):1433-40. doi: 10.2967/jnumed.110.085852. Epub 2011 Aug 17.

12.

Left ventricular assist device as bridge to liver transplantation in a patient with propionic acidemia and cardiogenic shock.

Ameloot K, Vlasselaers D, Dupont M, Meersseman W, Desmet L, Vanhaecke J, Vermeer N, Meyns B, Pirenne J, Cassiman D, De Laet C, Goyens P, Malekzadeh-Milan SG, Biarent D, Meulemans A, Debray FG.

J Pediatr. 2011 May;158(5):866-7; author reply 867. doi: 10.1016/j.jpeds.2010.12.031. Epub 2011 Feb 15. No abstract available.

PMID:
21324476
13.

In vitro differentiated adult human liver progenitor cells display mature hepatic metabolic functions: a potential tool for in vitro pharmacotoxicological testing.

Khuu DN, Scheers I, Ehnert S, Jazouli N, Nyabi O, Buc-Calderon P, Meulemans A, Nussler A, Sokal E, Najimi M.

Cell Transplant. 2011;20(2):287-302. doi: 10.3727/096368910X516655. Epub 2010 Aug 17.

PMID:
20719066
14.

Defining the pathogenesis of the human Atp12p W94R mutation using a Saccharomyces cerevisiae yeast model.

Meulemans A, Seneca S, Pribyl T, Smet J, Alderweirldt V, Waeytens A, Lissens W, Van Coster R, De Meirleir L, di Rago JP, Gatti DL, Ackerman SH.

J Biol Chem. 2010 Feb 5;285(6):4099-109. doi: 10.1074/jbc.M109.046920. Epub 2009 Nov 20.

15.

Subcomplexes of mitochondrial complex V reveal mutations in mitochondrial DNA.

Smet J, Seneca S, De Paepe B, Meulemans A, Verhelst H, Leroy J, De Meirleir L, Lissens W, Van Coster R.

Electrophoresis. 2009 Oct;30(20):3565-72. doi: 10.1002/elps.200900213.

PMID:
19862739
16.

Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI.

Muzard J, Sarda-Mantel L, Loyau S, Meulemans A, Louedec L, Bantsimba-Malanda C, Hervatin F, Marchal-Somme J, Michel JB, Le Guludec D, Billiald P, Jandrot-Perrus M.

PLoS One. 2009;4(5):e5585. doi: 10.1371/journal.pone.0005585. Epub 2009 May 18.

17.

Mercury tissue concentrations in various organs following a fatal intentional poisoning with mercury chloride.

Sabbe MB, Desruelles D, Meulemans A.

Clin Toxicol (Phila). 2008 Sep;46(8):783-4. No abstract available.

PMID:
19238744
18.

The use of technetium-99m radiolabeled human antimicrobial peptides for infection specific imaging.

Brouwer CP, Sarda-Mantel L, Meulemans A, Le Guludec D, Welling MM.

Mini Rev Med Chem. 2008 Sep;8(10):1039-52. Review.

PMID:
18782056
19.

Tolerance of adjuvant letrozole outside of clinical trials.

Fontaine C, Meulemans A, Huizing M, Collen C, Kaufman L, De Mey J, Bourgain C, Verfaillie G, Lamote J, Sacre R, Schallier D, Neyns B, Vermorken J, De Grève J.

Breast. 2008 Aug;17(4):376-81. doi: 10.1016/j.breast.2008.02.006. Epub 2008 May 2.

PMID:
18455395
20.

The many roads to infection imaging.

Welling M, Stokkel M, Balter J, Sarda-Mantel L, Meulemans A, Le Guludec D.

Eur J Nucl Med Mol Imaging. 2008 Apr;35(4):848-9. doi: 10.1007/s00259-007-0695-8. No abstract available.

21.

The aerobic forearm exercise test, a non-invasive tool to screen for mitochondrial disorders.

Meulemans A, Gerlo E, Seneca S, Lissens W, Smet J, Van Coster R, De Meirleir L.

Acta Neurol Belg. 2007 Sep;107(3):78-83.

PMID:
18072335
22.

Two novel mitochondrial DNA mutations in muscle tissue of a patient with limb-girdle myopathy.

Meulemans A, De Paepe B, De Bleecker J, Smet J, Lissens W, Van Coster R, De Meirleir L, Seneca S.

Arch Neurol. 2007 Sep;64(9):1339-43.

PMID:
17846276
23.

Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms.

Houard X, Rouzet F, Touat Z, Philippe M, Dominguez M, Fontaine V, Sarda-Mantel L, Meulemans A, Le Guludec D, Meilhac O, Michel JB.

J Pathol. 2007 May;212(1):20-8.

PMID:
17352452
24.

Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections.

Sarda-Mantel L, Saleh-Mghir A, Welling MM, Meulemans A, Vrigneaud JM, Raguin O, Hervatin F, Martet G, Chau F, Lebtahi R, Le Guludec D.

Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1302-9. Epub 2007 Mar 3.

PMID:
17334764
25.

A new family with the mitochondrial tRNAGLU gene mutation m.14709T>C presenting with hydrops fetalis.

Meulemans A, Seneca S, Smet J, De Paepe B, Lissens W, Van Coster R, Debeer A, De Meirleir L, Jaeken J.

Eur J Paediatr Neurol. 2007 Jan;11(1):17-20. Epub 2006 Dec 11.

PMID:
17161635
26.

Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis.

Aslangul E, Massias L, Meulemans A, Chau F, Andremont A, Courvalin P, Fantin B, Ruimy R.

Antimicrob Agents Chemother. 2006 Nov;50(11):3615-21.

27.

The influence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers.

Boeckxstaens GE, Tytgat GN, Wajs E, van Nueten L, de Ridder F, Meulemans A, Tack J.

Neurogastroenterol Motil. 2006 Oct;18(10):919-26.

PMID:
16961695
28.

A novel mitochondrial transfer RNA(Asn) mutation causing multiorgan failure.

Meulemans A, Seneca S, Lagae L, Lissens W, De Paepe B, Smet J, Van Coster R, De Meirleir L.

Arch Neurol. 2006 Aug;63(8):1194-8.

PMID:
16908752
29.

Serotonergic modulation of murine fundic tone.

Xue L, Camilleri M, Locke GR 3rd, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G.

Am J Physiol Gastrointest Liver Physiol. 2006 Dec;291(6):G1180-6. Epub 2006 Jul 27.

30.

Diagnostic value of immunostaining in cultured skin fibroblasts from patients with oxidative phosphorylation defects.

de Paepe B, Smet J, Leroy JG, Seneca S, George E, Matthys D, van Maldergem L, Scalais E, Lissens W, de Meirleir L, Meulemans A, van Coster R.

Pediatr Res. 2006 Jan;59(1):2-6. Epub 2005 Dec 2.

PMID:
16327006
31.

Molecular profiling of murine sensory neurons in the nodose and dorsal root ganglia labeled from the peritoneal cavity.

Peeters PJ, Aerssens J, de Hoogt R, Stanisz A, Göhlmann HW, Hillsley K, Meulemans A, Grundy D, Stead RH, Coulie B.

Physiol Genomics. 2006 Feb 14;24(3):252-63. Epub 2005 Nov 22.

PMID:
16303873
32.

Influence of ghrelin on interdigestive gastrointestinal motility in humans.

Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J, Peeters T.

Gut. 2006 Mar;55(3):327-33. Epub 2005 Oct 10.

33.

Paradoxic activation of the renin-angiotensin system in twin-twin transfusion syndrome: an explanation for cardiovascular disturbances in the recipient.

Mahieu-Caputo D, Meulemans A, Martinovic J, Gubler MC, Delezoide AL, Muller F, Madelenat P, Fisk NM, Dommergues M.

Pediatr Res. 2005 Oct;58(4):685-8.

PMID:
16189193
34.
35.

Effect of modulation of serotonergic, cholinergic, and nitrergic pathways on murine fundic size and compliance measured by ultrasonomicrometry.

Xue L, Locke GR, Camilleri M, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G.

Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G74-82. Epub 2005 Sep 15.

36.

Fatal family outbreak of Bacillus cereus-associated food poisoning.

Dierick K, Van Coillie E, Swiecicka I, Meyfroidt G, Devlieger H, Meulemans A, Hoedemaekers G, Fourie L, Heyndrickx M, Mahillon J.

J Clin Microbiol. 2005 Aug;43(8):4277-9.

37.

A mitochondrial tRNA aspartate mutation causing isolated mitochondrial myopathy.

Seneca S, Goemans N, Van Coster R, Givron P, Reybrouck T, Sciot R, Meulemans A, Smet J, Van Hove JL.

Am J Med Genet A. 2005 Aug 30;137(2):170-5.

PMID:
16059939
38.

Capillary electrophoresis of the electrochemical oxidation products of Ng-hydroxy-l-arginine at physiological pH.

Meulemans A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 25;824(1-2):308-11.

PMID:
16051531
39.

Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain.

Nijsen M, Ongenae N, Meulemans A, Coulie B.

Neurogastroenterol Motil. 2005 Jun;17(3):423-32.

PMID:
15916630
40.
41.

Characterization of 5-HT7-receptor-mediated gastric relaxation in conscious dogs.

Janssen P, Prins NH, Moreaux B, Meulemans AL, Lefebvre RA.

Am J Physiol Gastrointest Liver Physiol. 2005 Jul;289(1):G108-15. Epub 2005 Mar 3.

42.

Analysis of the mitochondrial encoded subunits of complex I in 20 patients with a complex I deficiency.

Meulemans A, Lissens W, Van Coster R, De Meirleir L, Smet J, Nassogne MC, Liebaers I, Seneca S.

Eur J Paediatr Neurol. 2004;8(6):299-306.

PMID:
15542384
43.

Survival after a lethal dose of arsenic trioxide.

Vantroyen B, Heilier JF, Meulemans A, Michels A, Buchet JP, Vanderschueren S, Haufroid V, Sabbe M.

J Toxicol Clin Toxicol. 2004;42(6):889-95.

PMID:
15533028
44.

Imaging apoptosis with (99m)Tc-annexin-V in experimental subacute myocarditis.

Peker C, Sarda-Mantel L, Loiseau P, Rouzet F, Nazneen L, Martet G, Vrigneaud JM, Meulemans A, Saumon G, Michel JB, Le Guludec D.

J Nucl Med. 2004 Jun;45(6):1081-6.

45.

Influence of 5-HT1 receptor agonists on feline stomach relaxation.

Janssen P, Tack J, Sifrim D, Meulemans AL, Lefebvre RA.

Eur J Pharmacol. 2004 May 25;492(2-3):259-67.

PMID:
15178373
46.

The mitochondrial interplay of ubiquinol and nitric oxide in endotoxemia.

Lisdero CL, Carreras MC, Meulemans A, Melani M, Aubier M, Boczkowski J, Poderoso JJ.

Methods Enzymol. 2004;382:67-81. Review. No abstract available.

PMID:
15047096
47.

In vivo characterization of 5-HT1A receptor-mediated gastric relaxation in conscious dogs.

Janssen P, Prins NH, Moreaux B, Meulemans AL, Lefebvre RA.

Br J Pharmacol. 2003 Nov;140(5):913-20. Epub 2003 Sep 29.

48.

Telemetric animal model to evaluate visceral pain in the freely moving rat.

Nijsen MJ, Ongenae NG, Coulie B, Meulemans AL.

Pain. 2003 Sep;105(1-2):115-23.

PMID:
14499427
50.

Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases.

Sarda L, Crémieux AC, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, Génin R, Delahaye N, Huten D, Le Guludec D.

J Nucl Med. 2003 Jun;44(6):920-6.

Supplemental Content

Loading ...
Support Center